Glass Medical AI develops explainable AI for computational pathology that helps pharma and biotech partners stratify patients for oncology and immunotherapy trials. Built on more than a decade of peer-reviewed research from the University of Amsterdam and the Netherlands Cancer Institute, its platform predicts response to immunotherapy from pathology data. The company is building a foundation model on a large clinical data set to support biomarker discovery and companion diagnostics. Glass Medical AI is dedicated to bringing effective treatments to the right patients faster.